rs146811868
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_004104.5(FASN):c.382G>A(p.Val128Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000856 in 1,612,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004104.5 missense
Scores
Clinical Significance
Conservation
Publications
- neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FASN | ENST00000306749.4 | c.382G>A | p.Val128Met | missense_variant | Exon 4 of 43 | 1 | NM_004104.5 | ENSP00000304592.2 | ||
| FASN | ENST00000634990.1 | c.382G>A | p.Val128Met | missense_variant | Exon 4 of 43 | 5 | ENSP00000488964.1 | |||
| FASN | ENST00000635197.1 | c.382G>A | p.Val128Met | missense_variant | Exon 4 of 4 | 3 | ENSP00000489514.1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152216Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000641 AC: 16AN: 249650 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000705 AC: 103AN: 1460464Hom.: 0 Cov.: 34 AF XY: 0.0000606 AC XY: 44AN XY: 726520 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000230 AC: 35AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74482 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.382G>A (p.V128M) alteration is located in exon 4 (coding exon 3) of the FASN gene. This alteration results from a G to A substitution at nucleotide position 382, causing the valine (V) at amino acid position 128 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Epileptic encephalopathy Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 128 of the FASN protein (p.Val128Met). This variant is present in population databases (rs146811868, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with FASN-related conditions. ClinVar contains an entry for this variant (Variation ID: 462046). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at